Breaking News

WuXi STA, Impact Therapeutics Enter Strategic Pact

WuXi STA will serve as Impact’s preferred contract development and manufacturing partner for its pipeline.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, and Impact Therapeutics, a biotech company focused on developing anti-cancer therapeutics, have signed a strategic partnership agreement under which WuXi STA will become the preferred contract development and manufacturing partner of Impact Therapeutics. WuXi STA will provide services covering the entire product development process of Impact’s pipeline of new drug candidates for both drug substance and drug product. The new p...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters